Robeco Institutional Asset Management B.V. Decreases Holdings in Synopsys, Inc. (NASDAQ:SNPS)

Robeco Institutional Asset Management B.V. cut its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 7.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,645 shares of the semiconductor company's stock after selling 3,633 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in Synopsys were worth $19,146,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Advisors Capital Management LLC raised its position in shares of Synopsys by 2.3% in the fourth quarter. Advisors Capital Management LLC now owns 840 shares of the semiconductor company's stock valued at $408,000 after buying an additional 19 shares during the last quarter. Barden Capital Management Inc. raised its holdings in Synopsys by 1.1% in the 4th quarter. Barden Capital Management Inc. now owns 1,832 shares of the semiconductor company's stock valued at $889,000 after acquiring an additional 20 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its stake in Synopsys by 28.6% in the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock worth $44,000 after purchasing an additional 20 shares in the last quarter. Peninsula Wealth LLC boosted its holdings in shares of Synopsys by 0.5% during the 4th quarter. Peninsula Wealth LLC now owns 4,224 shares of the semiconductor company's stock worth $2,050,000 after purchasing an additional 20 shares during the last quarter. Finally, Williams Jones Wealth Management LLC. boosted its holdings in shares of Synopsys by 0.5% during the 4th quarter. Williams Jones Wealth Management LLC. now owns 4,650 shares of the semiconductor company's stock worth $2,257,000 after purchasing an additional 22 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently commented on SNPS. KeyCorp set a $540.00 price objective on Synopsys in a research report on Tuesday, June 3rd. Rosenblatt Securities cut their target price on Synopsys from $660.00 to $625.00 and set a "buy" rating for the company in a research note on Thursday, May 29th. Needham & Company LLC reiterated a "buy" rating and set a $650.00 price target on shares of Synopsys in a report on Thursday, May 29th. Stifel Nicolaus set a $550.00 price objective on shares of Synopsys in a report on Monday, April 28th. Finally, Mizuho cut their price objective on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $607.14.

Insiders Place Their Bets

In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the completion of the sale, the chief executive officer now directly owns 71,589 shares of the company's stock, valued at approximately $32,782,750.77. This trade represents a 13.70% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CRO Richard S. Mahoney sold 9,010 shares of Synopsys stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the completion of the sale, the executive now directly owns 1,485 shares in the company, valued at approximately $699,746.85. The trade was a 85.85% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 27,686 shares of company stock valued at $13,001,048. 0.62% of the stock is currently owned by insiders.

Synopsys Trading Up 2.5%

NASDAQ:SNPS traded up $12.41 on Monday, reaching $515.04. 201,080 shares of the company's stock were exchanged, compared to its average volume of 1,161,168. The firm has a market capitalization of $79.91 billion, a price-to-earnings ratio of 37.19, a price-to-earnings-growth ratio of 3.32 and a beta of 1.11. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $624.80. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01. The business has a fifty day moving average of $479.33 and a 200-day moving average of $477.10.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.40 by $0.27. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.60 billion. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The firm's quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the business earned $3.00 EPS. As a group, analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.